Considering those patients who have received prior radiation therapy and who have also shown significantly higher expression of PD-L1, PD1 blockade therapy is considered a potential, viable and successful treatment strategy to treat patients with high grade and also recurrent meningiomas. The gene discussed is CD274; the disease is meningioma.